The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Webcasts|November 20, 2019
Editors' Series: The Importance of In-House Testing for Cannabis and Hemp Businesses
Author(s)Sartorius
Cannabis is medicine and it should be tested like medicine. This means the cannabis industry needs to adopt the pharmaceutical industry testing paradigm of cradle to grave testing. This webcast will discuss the technologies available for in-house testing, and how it can increase profitability and reduce compliance failures. Live: Wednesday, Nov. 20, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CETOn demand available after airing until Nov. 20, 2020.
Register Free:
Event Overview:
Cannabis is medicine and it should be tested like medicine. This means the cannabis industry needs to adopt the pharmaceutical industry testing paradigm of cradle to grave testing. Our industry needs to test raw materials, after each manufacturing step, and the final product to insure the safety and efficacy of the medicines we manufacture. Sending samples out to third party labs is not practical because the results take too long, which is why cannabis businesses need to do their own testing. The technologies available for this as well as how in-house testing can increase profitability and reduce compliance failures will be discussed.
Key Learning Objectives:
- Technology available for in-house testing
- How can in-house testing increase profitability in the cannabis industry
- How can in-house testing reduce compliance failures in cannabis
- Cradle to grave cannabis testing
Time and date: Wednesday, Nov. 20, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
On demand available after airing until Nov. 20, 2020.
Sponsor: Sartorius
Register Free:
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!